Laboratory results that should be ignored

MedGenMed Medscape General Medicine

Volumn 8, Issue 4, 2006, Pages

  Elston, Dirk M ^a  

^a GEISINGER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ANALYTIC METHOD; ANALYTICAL ERROR; ARTICLE; CLINICAL PRACTICE; DATA ANALYSIS; DECISION MAKING; FALSE POSITIVE RESULT; GOOD LABORATORY PRACTICE; HUMAN; INFORMATION PROCESSING; INTERPERSONAL COMMUNICATION; LABORATORY TEST; MEDICAL ERROR; MICROBIOLOGICAL EXAMINATION; OUTCOME ASSESSMENT; PATHOLOGICAL ANATOMY; PATIENT IDENTIFICATION; POLYMERASE CHAIN REACTION; QUALITY CONTROL; SENSITIVITY AND SPECIFICITY; DIAGNOSIS, MEASUREMENT AND ANALYSIS; DIAGNOSTIC ERROR; LABORATORY DIAGNOSIS; REVIEW; STANDARD;

CLINICAL LABORATORY TECHNIQUES; DIAGNOSTIC ERRORS; FALSE POSITIVE REACTIONS; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; QUALITY CONTROL;

EID: 33749989341     PISSN: 15310132     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (74)

1. Rivers PA, Dobalian A, Germinario FA. A review and analysis of the clinical laboratory improvement amendment of 1988: compliance plans and enforcement policy. Health Care Manage Rev. 2005;30:93-102. Abstract
2. Johnson PR. The contribution of proficiency testing to improving laboratory performance and ensuring quality patient care. Clin Leadersh Manag Rev. 2004;18:335-341. Abstract
3. Howanitz PJ. Errors in laboratory medicine: practical lessons to improve patient safety. Arch Pathol Lab Med. 2005;129:1252-1261. Abstract
4. Stankovic AK. The laboratory is a key partner in assuring patient safety. Clin Lab Med. 2004;24:1023-1035. Abstract
5. Saxena S, Kempf R, Wilcox S, et al. Critical laboratory value notification: a failure mode effects and criticality analysis. Jt Comm J Qual Patient Saf. 2005;31:495-506. Abstract
6. Ricos C, Garcia-Victoria M, de la Fuente B. Quality indicators and specifications for the extra-analytical phases in clinical laboratory management. Clin Chem Lab Med. 2004;42:578-582. Abstract
7. Barenfanger J, Sautter RL, Lang DL, Collins SM, Hacek DM, Peterson LR. Improving patient safety by repeating (read-back) telephone reports of critical information. Am J Clin Pathol. 2004;121:801-803. Abstract
8. Berle LM. Patient safety: getting there from here - quality management is the best patient safety program. Clin Leadersh Manag Rev. 2004;18:311-315. Abstract
9. Bachner P. Quality assurance of the analytic process: pre- and postanalytic variation. Clin Lab Med. 1986;6:613-623. Abstract
10. Saarela U, Kivinen T, Sarkkinen H. External failures as descriptor of quality in clinical microbiology laboratory services. Clin Chem Lab Med. 2005;43:54-63. Abstract
11. Nichols JH, Bartholomew C, Brunton M, et al. Reducing medical errors through barcoding at the point of care. Clin Leadersh Manag Rev. 2004;18:328-334. Abstract
12. Shaw R, Coia JE, Michie J. Use of bar code readers and programmable keypads to improve the speed and accuracy of manual data entry in the clinical microbiology laboratory: experience of two laboratories. J Clin Pathol. 1999;52:54-60. Abstract
13. Bates DW, Cohen M, Leape LL, Overhage JM, Shabot MM, Sheridan T. Reducing the frequency of errors in medicine using information technology. J Am Med Inform Assoc. 2001;8:299-308. Abstract
14. Aller RD, Friedman W. Rapid accurate entry of microbiology results. Arch Pathol Lab Med. 1996;120:57-61. Abstract
15. White GH. Trusting numbers: uncertainty and the pathology laboratory. MJA. 2002;177:153-155. Available at: www.mja.com.au/public/issues/ 177_03_050802/whi10784_fm.html Accessed September 29, 2006.
16. Cole LA. Use of hCG tests for evaluating trophoblastic diseases: choosing an appropriate hCG assay, false detection of hCG, unexplained elevated hCG, and quiescent trophoblastic disease. USA hCG Reference Service Report. 2002. Available at: http://www.hcglab.com/ hCG%20Ref%20Service% 20Reprort%202001.htm Accessed September 25, 2006.
17. Selby C. Interference in immunoassay. Ann Clin Biochem. 1999;36:704-721. Abstract
18. Ismail AAA, Barth JH. Wrong biochemistry results. BMJ. 2001;323:705-706. Abstract
19. Fitzmaurice TF, Brown C, Rifai N, et al. False increase of cardiac troponin 1 with heterophilic antibodies. Clin Chem. 1998;44:2212-2214. Abstract
20. Krahn J, Parry DM, Laroux M, Dalton J. High percentage of false positive cardiac troponin 1 results in patients with rheumatoid factor. Clin Biochem. 1999;32:477-480. Abstract
21. Hayden RT, Frenkel LD. More laboratory testing: greater cost but not necessarily better. Pediatr Infect Dis J. 2000;19:290-292. Abstract
22. Hammerschlag MR, Ajl S, Laraque D. Inappropriate use of nonculture tests for the detection of Chlamydia trachomatis in suspected victims of child sexual abuse: a continuing problem. Pediatrics. 1999;104(pt1):1137-1139.
23. Lum G, Freeman K, Nguyen NL, et al. A cluster of culture positive gonococcal infections but with false negative cppB gene based PCR. Sex Transm Infect. 2005;81:400-402. Abstract
24. Whiley DM, Tapsall JW, Sloots TP. Nucleic acid amplification testing for Neisseria gonorrhoeae: an ongoing challenge. J Mol Diagn. 2006;8:3-15. Abstract
25. Katz AR, Effler PV, Ohye RG, Brouillet B, Lee MV, Whiticar PM. False-positive gonorrhea test results with a nucleic acid amplification test: the impact of low prevalence on positive predictive value. Clin Infect Dis. 2004;38:814-819. Abstract
26. Smith DW, Tapsall JW, Lum G. Guidelines for the use and interpretation of nucleic acid detection tests for Neisseria gonorrhoeae in Australia: a position paper on behalf of the Public Health Laboratory Network. Commun Dis Intell. 2005;29:358-365. Abstract
27. Geraats-Peters CW, Brouwers M, Schneeberger PM, et al. Specific and sensitive detection of Neisseria gonorrhoeae in clinical specimens by real-time PCR. J Clin Microbiol. 2005;43:5653-5659. Abstract
28. Airell A, Lindback E, Ataker F, Pornull KJ, Wretlind B. Verification of clinical samples, positive in AMPLICOR Neisseria gonorrhoeae polymerase chain reaction, by 16S rRNA and gyrA compared with culture. Int J STD AIDS. 2005;16:415-419. Abstract
29. Whiley DM, Buda PJ, Bayliss J, Cover L, Bates J, Sloots TP. A new confirmatory Neisseria gonorrhoeae real-time PCR assay targeting the porA pseudogene. Eur J Clin Microbiol Infect Dis. 2004;23:705-710. Abstract
30. Ender PT, Durning SJ, Woelk WK, et al. Pseudo-outbreak of methicillin-resistant Staphylococcus aureus. Mayo Clin Proc. 1999;74:885-889. Abstract
31. Nsutebu EF, Ndumbe PM, Koulla S. The increase in occurrence of typhoid fever in Cameroon: overdiagnosis due to misuse of the Widal test? Trans R Soc Trop Med Hyg. 2002;96:64-67.
32. Zarbo RJ, Meier FA, Flaab SS. Error detection in anatomic pathology. Arch Pathol Lab Med. 2005;129:1237-1245. Abstract
33. Argenyi ZB, Balogh K, Abraham AA. Degenerative ("ancient") changes in benign cutaneous schwannoma. A light microscopic, histochemical and immunohistochemical study. J Cutan Pathol. 1993; 20:148-153. Abstract
34. Hornick JL, Fletcher CD. Soft tissue perineurioma: clinicopathologic analysis of 81 cases including those with atypical histologic features. Am J Surg Pathol. 2005;29:845-858. Abstract
35. Kerl H, Soyer HP, Cerroni L, Wolf IH, Ackerman AB. Ancient melanocytic nevus. Semin Diagn Pathol. 1998; 15:210-215. Abstract
36. Kamino H, Lee JY, Berke A. Pleomorphic fibroma of the skin: a benign neoplasm with cytologic atypia. A clinicopathologic study of eight cases. Am J Surg Pathol. 1989; 13:107-113. Abstract
37. Tamada S, Ackerman AB. Dermatofibroma with monster cells. Am J Dermatopathol. 1987;9:380-387. Abstract
38. Layfield LJ, Bentley RC, Mirra JM. Pseudoanaplastic giant cell tumor of bone. Arch Pathol Lab Med. 1999;123:163-166. Abstract
39. Goodman WT, Bang RH, Padilla RS. Giant dermatofibroma with monster cells. Am J Dermatopathol. 2002;24:36-38. Abstract
40. Laposata ME, Laposata M, Van Cott EM, Buchner DS, Kashalo MS, Dighe AS. Physician survey of a laboratory medicine interpretive service and evaluation of the influence of interpretations on laboratory test ordering. Arch Pathol Lab Med. 2004;128:1424-1427. Abstract
41. Laposata M. Patient-specific narrative interpretations of complex clinical laboratory evaluations: who is competent to provide them? Clin Chem. 2004;50:471-472.
42. Covell DG, Uman GC, Manning PR. Information needs in office practice: are they being met? Am J Med. 2000;109:218-223.
43. Bernstein RM, Hollingworth GR, Wood WE. Prompting physicians for cost-effective test ordering in the low prevalence conditions of family medicine. Proc Annu Symp Comput Appl Med Care. 1994;824-828.
44. Tandberg D, Deely JJ, O'Malley AJ. Generalized likelihood ratios for quantitative diagnostic test scores. Am J Emerg Med. 1997;15:694-699. Abstract
45. McNeely MD. Computerized interpretation of laboratory tests: an overview of systems, basic principles and logic techniques. Clin Biochem. 1983;16:141-146. Abstract
46. Swezey CB, Jacobson W. Computer-based diagnostic reporting for serum electrolytes. Am J Clin Pathol. 1980;74:812-819. Abstract
47. Trendelenburg C, Colhoun O, Wormek A, Massey KL. Knowledge-based test result in interpretation in laboratory medicine. Clin Chim Acta. 1998;278:229-242. Abstract
48. Pribor HC. Expert systems in laboratory medicine: a practical consultative application. J Med Syst. 1989;13:103-109. Abstract
49. Regeniter A, Steiger JU, Scholer A, Huber PR, Siede WH. Windows to the ward: graphically oriented report forms. Presentation of complex, interrelated laboratory data for electrophoresis/immunofixation, cerebrospinal fluid, and urinary protein profiles. Clin Chem. 2003;49:41-50. Abstract.
50. Jones GR. Effect of the reporting-interval size on critical difference estimation: beyond "2.77." Clin Chem. 2006;52:880-885.
51. Holvoet P, Macy E, Landeloos M, Jones D, Nancy JS, Van de Werf F, Tracy RP. Analytical performance and diagnostic accuracy of immunometric assays for the measurement of circulating oxidized LDL. Clin Chem. 2006;52:760-764. Abstract
52. Waghorn DJ. Actinobaculum massiliae: a new cause of superficial skin infection. J Infect. 2004;48:276-277. Abstract
53. Berg G, Eberl L, Hartmann A. The rhizosphere as a reservoir for opportunistic human pathogenic bacteria. Environ. Microbiol. 2005;7:1673-1685. Abstract
54. Kuipers EJ, Michetti P. Bacteria and mucosal inflammation of the gut: lessons from Helicobacter pylori. Helicobacter. 2005;10(suppl1):66-70.
55. Peipert JF. Actinomyces: normal flora or pathogen? Obstet Gynecol. 2004;104(pt2):1132-1133.
56. Waites KB. Effective communication of antimicrobial susceptibility data by pathologists to clinicians. Adv Exp Med Biol. 2005;563:165-177. Abstract
57. Lim EM, Sikaris KA, Gill J, et al. Quality assessment of interpretative commenting in clinical chemistry. Clin Chem. 2004;50:632-637. Abstract
58. Dons RF. Interpretive reporting of laboratory data: proposed criteria to qualify as a high-quality, limited clinical pathology consultation. Endocr Pract. 1996;2:255-260. Abstract
59. American College of Obstetricians and Gynecologists Committee on Quality Assessment. ACOG criteria set. Atypical squamous cells of undetermined significance (ASCUS). Int J Gynaecol Obstet. 1996;52:215-216. Abstract
60. Gurbuz A, Karateke A, Kabaca C, Kir G. Atypical glandular cells: improvement in cytohistologic correlation by the 2001 Bethesda system. Int J Gynecol Cancer. 2005;15:903-910. Abstract
61. Gonzalez D, Hernandez E, Anderson L, Heller P, Atkinson BF. Clinical significance of a cervical cytologic diagnosis of atypical squamous cells of undetermined significance. Favoring a reactive process or low grade squamous intraepithelial lesion. J Reprod Med. 1996;41:719-723. Abstract
62. Reichlin M. Laboratory tests used in the diagnosis of lupus. Washington, DC: Lupus Foundation of America. 2005. Available at: http://www.lupus.org/education/brochures/labtests.html Accessed September 25, 2006.
63. Schledermann D, Ejersbo D, Hoelund B. Significance of atypia in conventional Papanicolaou smears and liquid-based cytology: a follow-up study. Cytopathology. 2004;15:148-153. Abstract
64. Levi AW, Kelly DP, Rosenthal DL, Ronnett BM. Atypical squamous cells of undetermined significance in liquid-based cytologic specimens: results of reflex human papillomavirus testing and histologic follow-up in routine practice with comparison of interpretive and probabilistic reporting methods. Cancer. 2003;99:191-197. Abstract
65. McIntosh MW, Urban N, Karlan B. Generating longitudinal screening algorithms using novel biomarkers for disease. Cancer Epidemiol Biomarkers Prev. 2002;11:159-166. Abstract
66. van der Weijden T, van Bokhoven MA, Dinant GJ, van Hasselt CM, Grol RP. Understanding laboratory testing in diagnostic uncertainty: a qualitative study in general practice. Br J Gen Pract. 2002;52:974-980. Abstract
67. Board N, Brennan N, Caplan G. Use of pathology services in re-engineered clinical pathways. J Qual Clin Pract. 2000;20:24-29. Abstract
68. Dons RF. Interpretive reporting of laboratory data: proposed criteria to qualify as a high-quality, limited clinical pathology consultation. Endocr Pract. 1996;2:255-260. Abstract
69. Yamauchi K, Fukatsu T. A decision support system for diagnostic consultation in laboratory tests. Medinfo. 1995;8(pt2):1034.
70. Boon-Falleur L, Sokal E, Nightingale PG. Utilization of laboratory resources: developments in knowledge-based ordering systems. Int J Biomed Comput. 1995;40:17-30. Abstract
71. Plapp FV, Essmyer CE, Byrd AB, Zucker ML. How to successfully influence laboratory test utilization. Clin Leadersh Manag Rev. 2000;14:253-260. Abstract
72. Sucov A, Bazarian JJ, deLahunta EA, Spillane L. Test ordering guidelines can alter ordering patterns in an academic emergency department. J Emerg Med. 1999;17:391-397. Abstract
73. Anita J. Slomski AJ. Innovations in pathology: improving laboratory use. Northfield, III: College of American Pathologists. Available at: http://www.cap.org/apps/docs/cap_today/feature_stories/ innovations_lab_use_feature.html Accessed September 25, 2006.
74. Sonnenberg A. Personal view: 'don't ask, don't tell' - the undesirable consequences of incidental test results in gastroenterology. Aliment Pharmacol Ther. 2004;20:381-387. Abstract